Abstract: This invention pertains to an improvement in the treatment of autoimmune diseases. More specifically, the invention is directed to the use of bystander antigens (i.e. antigens that suppress cells involved in the autoimmune process) for the treatment of autoimmune diseases. The invention also includes pharmaceutical formulations comprising bystander antigens useful in the treatment of autoimmune diseases in mammals.
Type:
Application
Filed:
August 11, 2003
Publication date:
June 17, 2004
Applicant:
Autolmmune Inc.
Inventors:
Howard Weiner, Ariel Miller, Zhengyi Zhang, Ahmad Al-Sabbagh